Is this your app? Claim this page to add your own description, links and contact info. It's free. →

Assess the Risk: GIST

Assess the Risk: GIST at Mac App Store analyse

Novartis Pharmaceuticals Corporation
5,111 ratings · Power index: 100
Version 1.0
Size 1.77 Mb
Updated 9 years ago
Released 05 May 2013

How do you feel about this app?

Screenshots

Description

An interactive activity designed for use on an iPad, this program estimates the risk of recurrence in gastrointestinal stromal tumor (GIST)—a GI cancer—using various assessment methodologies. The application features 4 hypothetical GIST patients and allows you to select input for key tumor-related prognostic factors. The recurrence risk is then calculated utilizing 3 risk assessment tools, which were developed in conjunction with government institutes and major cancer organizations. It is intended as an educational exercise for use by oncologists and other healthcare professionals who are involved in the evaluation of patients after resection of a primary GIST. Information is presented for educational purposes only. Results not intended for use in treatment decisions. This easy-to-use application underscores not only the importance of assessing the risk of recurrence, but also how the estimated risk is influenced by various prognostic factors, as well as the selected assessment approach.

Estimates

Monthly Downloads > 2.2k
Est. Revenue ~ $900

Availability

Devices

iPad2Wifi iPad23G iPadThirdGen iPadThirdGen4G iPadFourthGen iPadFourthGen4G iPadMini iPadMini4G iPadAir iPadAirCellular iPadMiniRetina iPadMiniRetinaCellular iPadAir2 iPadAir2Cellular iPadMini3 iPadMini3Cellular iPadMini4 iPadMini4Cellular iPadPro iPadProCellular iPadPro97 iPadPro97Cellular

Pricing by country

Country Price
USA free